Sionna Therapeutics, Inc. (SION)
4.90
0.00 (0.00%)
USD |
NASDAQ |
Oct 09, 16:00
4.895
0.00 (0.00%)
After-Hours: 20:00
Sionna Therapeutics Free Cash Flow (Quarterly) : -22.22M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -22.22M |
| March 31, 2026 | -21.84M |
| December 31, 2025 | -16.83M |
| September 30, 2025 | -15.32M |
| June 30, 2025 | -18.15M |
| Date | Value |
|---|---|
| March 31, 2025 | -16.37M |
| December 31, 2024 | -11.81M |
| September 30, 2024 | -17.69M |
| June 30, 2024 | -10.14M |
| March 31, 2024 | -13.18M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Vertex Pharmaceuticals, Inc. | 1.013B |
| Capricor Therapeutics, Inc. | -37.39M |
| ARS Pharmaceuticals, Inc. | -60.93M |
| ACADIA Pharmaceuticals, Inc. | 95.69M |
| Immunic, Inc. | -31.25M |